Tendie Bot

Tendie.bot

Login
PCSA Articles
reddit/

PCSA (Processa Pharmaceuticals) Rockets 27% on Reddit Penny Stock Buzz

PCSA (Processa Pharmaceuticals) was a top-10 ticker by Reddit score on October 9, with a sentiment score of 0.71. A potential multi-hundred-million licensing deal for its gastroparesis drug was the primary catalyst discussed on r/pennystocks, alongside a broader penny stock analysis thread that highlighted the stock's low float. No same-day news articles were available.

  1. PCSA surged to a top-7 position on Reddit’s ticker ranking, driven by a binding term sheet for a potential $454M+ licensing deal with Intact Therapeutics.

  2. Retail sentiment on the stock reached 0.71 (bullish), with active discussions on r/pennystocks emphasizing the microcap biotech’s low float and high potential upside.

  3. A mathematical analysis thread compared PCSA to other high-chatter tickers like YYAI and SCWO, citing its low market cap and float as catalysts for volatility.

Shares of

PCSA
$PCSA were among the most intensely discussed names on Reddit Thursday, climbing to rank #7 in the Tendie.bot ticker ranking. With 166 comments and 249 upvotes across 9 posts, the microcap biotech generated a sentiment score of 0.71 — heavily bullish — as retail traders piled into another penny stock narrative.

The Big Catalyst: A Potential $454M Licensing Deal

The primary driver of the buzz was a single high-engagement post on r/pennystocks titled “$PCSA has a potential $454M+ licensing deal on the table.” The post highlighted a binding term sheet signed with Intact Therapeutics for

PCSA
$PCSA’s drug candidate PCS12852, which targets gastroparesis and gastrointestinal motility disorders. According to the post, the deal structure includes a $2.5 million option fee, up to $20 million in development and regulatory milestones, over $432 million in commercial milestone payments, and double-digit royalties on sales outside of South Korea.

Retail-focused subreddits embraced the deal as evidence of institutional conviction. The post’s author emphasized that the term sheet was “company-disclosed, verifiable,” and that it could be “transformational” for a company trading at microcap valuations. The post received 110 upvotes and generated 30 comments.

PCSA

Low Float + High Chatter = Volatility

A separate thread comparing penny stocks from a “mathematical perspective” also boosted

PCSA
$PCSA’s visibility. That post — with 167 upvotes and 261 comments — argued that a stock’s upside potential depends less on price per share and more on market capitalization and float ratios.
PCSA
$PCSA was listed alongside YYAI, GPUS, BURU, SCWO, and SHOT as tickers showing recent spikes in volume and chatter.

Another Reddit user pointed to a technical pattern in

PCSA
$PCSA’s price action, noting that “dips are being absorbed and bought up” and that the setup looked similar to a previous session that led to a gap higher. The post attracted 68 upvotes and reinforced the view that retail traders were actively accumulating the stock during intraday pullbacks.

No Fresh News — Pure Retail Narrative

No same-day earnings, SEC filings, or analyst ratings were available for

PCSA
$PCSA on October 9. The entire move was driven by Reddit conversation re-litigating a previously disclosed licensing term sheet and blending it with the mechanics of low-float trading. That made
PCSA
$PCSA a pure retail-narrative stock for the day, with r/pennystocks serving as the primary forum. The subreddit posted 184 threads on the ticker overall Thursday, with an average sentiment of 0.64.

Subscribe to Tendie.bot for more market recaps.